Understanding the metabolic role of colonic L cells is particularly relevant because the distal gut harbours the majority of endogenous GLP-1 and PYY stores and recruiting this L cell population could be developed as a therapeutic strategy for diabetes and obesity, provided the hormones exhibit metabolic activity when released from this region. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.